新辅助化疗不能被视为晚期卵巢癌的常规治疗策略。
Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of advanced ovarian cancer.
机构信息
Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Studiengruppe, Germany.
出版信息
Int J Gynecol Cancer. 2012 Feb;22(2):182-5. doi: 10.1097/IGC.0b013e31821d419a.
PMID:22274314
Abstract
Minority vote to statement A5 of the Fourth Ovarian Cancer Consensus Conference, Vancouver 2010, on behalf of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Germany plus North-Eastern Society of Gyneco-Oncology and the AGO Austria.
摘要
少数人投票赞成 2010 年温哥华第四届卵巢癌共识会议的 A5 号声明，代表德国妇科肿瘤学工作组（Arbeitsgemeinschaft Gynaekologische Onkologie，AGO）、北欧妇科肿瘤学会和奥地利 AGO。
Zotero 插件